Effect of protein kinase inhibitors on activity of mammalian small heat- shock protein (HSP25) Kinase

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1239-1247

  Hayess, Katrin ^a   Benndorf, Rainer ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Ehrlich ascites tumor cells; Heat shock protein; HSP25; Inhibitors; Phosphorylation; Protein serine threonine kinase

Indexed keywords

HEAT SHOCK PROTEIN; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; QUERCETIN; STAUROSPORINE; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; DRUG EFFECT; DRUG PROTEIN BINDING; EHRLICH ASCITES TUMOR CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; CARBAZOLES; CARCINOMA, EHRLICH TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT-SHOCK PROTEINS; HUMANS; MICE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; STAUROSPORINE;

EID: 0030739229     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00877-5     Document Type: Article

References (43)

1. Huot J, Lambert H, Lavoie JN, Guimond A, Houle F and Landry J, Characterization of 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat-shock protein HSP27. Eur J Biochem 227: 416-427, 1995.
2. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J and Lutsch G, Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization inhibiting activity. J Biol Chem 269: 20780-20784, 1994.
3. Lavoie JN, Lambert H, Hickey E, Weber LA and Landry J, Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 15: 505-516, 1995.
4. Benndorf R, Hayess K, Stahl J and Bielka H, Cell-free phosphorylation of the murine small heat shock protein hsp25 by an endogenous kinase from Ehrlich ascites tumor cells. Biochim Biophys Acta 1136: 203-207, 1992.
5. Stokoe D, Caudwell B, Cohen PTW and Cohen P, The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochemical J 296: 843-849, 1993.
6. Guesdon F, Freshney N, Waller RJ, Rawlinson L and Saklatvala J, Interleukin 1 and tumor necrosis factor stimulate two novel protein kinases that phosphorylate the heat shock protein hsp27 and beta-casein. J Biol Chem 268: 4236-4243, 1993.
7. Zu Y-L, Wu F, Gilchrist A, Ai Y, Labadia ME and Huang C-K, The primary structure of a human MAP kinase activated protein kinase 2. Biochem Biophys Res Commun 200: 1118-1124, 1994.
8. Engel K, Plath K and Gaestel M, The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain. FEBS Lett 336: 143-147, 1994.
9. Stokoe D, Engel K, Campbell DG, Cohen P and Gaestel M, Identification of MAPKAP kinase-2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 313: 307-313, 1992.
10. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T and Nebreda AR, A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037, 1994.
11. ++ dependent protein kinase. Biochem Biophys Res Commun 135: 397-402, 1986.
12. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A and Kaneko M, K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142: 436-440, 1987.
13. Umezawa K and Imoto M, Use of erbstatin as protein-tyrosine kinase inhibitor. Methods Enzymol 201: 379-385, 1991.
14. Levitzki A, Gazit A, Osherov N, Posner J and Gilon C, Inhibition of protein-tyrosine kinases by tyrphostins. Methods Enzymol 201: 347-370, 1991.
15. Hidaka H and Kobayashi R, Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32: 377-397, 1992.
16. Kemp BE, Pearson RB and House C, Pseudosubstrate-based peptide inhibitors. Methods Enzymol 201: 287-316, 1991.
17. Engel K, Schultz H, Martin F, Kotlyarov A, Plath K, Hahn M, Heinemann U and Gaestel M, Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem 270: 1-9, 1995.
18. House C and Kemp BE, Protein kinase C contains a pseudo-substrate prototope in its regulatory domain. Science 238: 1726-1728, 1987.
19. Payne ME, Fong YL, Ono T, Colbran RJ, Kemp BE, Soderling TR and Means AR, Calcium/calmodulin-dependent protein kinase II. Characterization of distinct calmodulin binding and inhibitory domains. J Biol Chem 263: 7190-7195, 1988.
20. Kemp BE, Pearson RB, Guerriero V Jr, Bagchi IC and Means AR, The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudo-substrate sequence. J Biol Chem 262: 2542-2548, 1987.
21. Zu YL, Ai YX and Huang CK, Characterization of an auto-inhibitory domain in human mitogen-activated protein kinase-activated protein kinase-2. J Biol Chem 270: 202-206, 1995.
22. Benndorf R, Nürnberg P and Bielka H, Growth phase-dependent proteins of the Ehrlich ascites tumor analyzed by one- and two-dimensional electrophoresis. Exp Cell Res 174: 130-138, 1988.
23. Benndorf R, Kraft R, Otto A, Stahl J, Böhm H and Bielka H, Purification of the growth-related protein p25 of the Ehrlich ascites tumor and analysis of its isoforms. Biochem Int 17: 225-234, 1988.
24. Laemmli UK, Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227: 680-685, 1970.
25. Roskoski R Jr, Assays of protein kinase. Methods Enzymol 99: 3-6, 1983.
26. Plath K, Engel K, Schwedersky G and Gaestel M, Characterization of the proline-rich region of mouse MAPKAP kinase 2: Influence on catalytic properties and binding to the c-abl SH3 domain in vitro. Biochem Biophys Res Commun 203: 1188-1194, 1994.
27. Gaestel M, Schröder W, Benndorf R, Lippmann C, Buchner K, Hucho F, Erdmann VA and Bielka H, Identification of the phosphorylation sites of the small murine heat shock protein hsp25. J Biol Chem 266: 14721-14725, 1991,
28. Landry J, Lambert H, Zhou M, Lavoie JN, Hickey E, Weber LA and Anderson CW, Human hsp27 is phosphorylated by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 267: 794-803, 1992.
29. cdc2-like kinases. Biochem Biophys Res Commun 184: 80-85, 1992.
30. Niggli V and Keller H, On the role of protein kinases in regulating neutrophil actin association with the cytoskeleton. J Biol Chem 266: 7927-7932, 1991.
31. 2+/calmodulin-dependent protein kinase II by K252a and its derivative, KT5926. Biochem Biophys Res Commun 181: 423-429, 1991.
32. Nakanishi S, Yamada K, Iwahashi K, Kuroda K and Kase H, KT5926, a potent and selective inhibitor of myosin light chain kinase. Mol Pharmacol 37: 482-488, 1990.
33. Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers SJ, Marshall C and Cohen P, MAPKAP kinase-2: A novel protein kinase activated by mitogen-activated protein kinase. EMBO J 11: 3985-3994, 1992.
34. Jinsart W, Ternai B and Polya GM, Inhibition of rat liver cyclic AMP-dependent protein kinase by flavonoids. Biol Chem Hoppe-Seyler 373: 205-211, 1992.
35. Horn F, Gschwendt M and Marks-F, Partial purification and characterization of the calcium-dependent and phospholipid-dependent protein kinase C from chick oviduct. Eur J Biochem 148: 533-538, 1985.
36. Graziani Y, Erikson E and Erikson RL, The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo. Eur J Biochem 135: 583-589, 1983.
37. Daikoku T, Yamashita Y, Tsurumi T, Maeno K and Nishiyama Y, Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2. Virology 197: 685-694, 1993.
38. Bishop WR, Petrin J, Wang L, Ramesh U and Doll RJ, Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin. Biochem Pharmacol 40: 2129-2135, 1990.
39. Levitzki A, Tyrphostins: Tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J 6: 3275-3281, 1992.
40. Gazit A, Yaish P, Gilon C and Levitzki A, Tyrphostins I: Synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32: 2344-2352, 1989.
41. Gazit A, Osherov N, Posner I, Yaish P, Poradosu E, Gilon C and Levitzki A, Tyrphostins: 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem 34: 1896-1907, 1991.
42. Kemp BE and Pearson RB. Protein kinase recognition sequence motifs. Trends Biochem Sci 15: 342-346, 1990.
43. Knighton DR, Zheng J, Ten Eyck LF, Xuong N-H, Taylor SS and Sowadski JM, Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253: 414-420, 1991.